| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.31 | 4e-20 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-10 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-08 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.21 | 1e-05 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-05 |